{"count": 10, "results": [{"_id": "36127484", "pmid": 36127484, "pmcid": "PMC10349728", "title": "Modulation of radiosensitivity of DU145 prostate carcinoma cells by simvastatin", "journal": "J Cancer Res Clin Oncol", "authors": ["Korte V", "Gademann G", "Gawish A", "Ochel HJ"], "date": "2022-09-21T00:00:00Z", "doi": "10.1007/s00432-022-04364-9", "meta_date_publication": "2022 Sep 21", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50273.273, "text_hl": "Modulation of radiosensitivity of @CELLLINE_CVCL:0105 @@@DU145@@@ @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostate carcinoma@@@ cells by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@", "citations": {"NLM": "Korte V, Gademann G, Gawish A, Ochel HJ. Modulation of radiosensitivity of DU145 prostate carcinoma cells by simvastatin J Cancer Res Clin Oncol. 2022 Sep 21;():. PMID: 36127484", "BibTeX": "@article{36127484, title={Modulation of radiosensitivity of DU145 prostate carcinoma cells by simvastatin}, author={Korte V and Gademann G and Gawish A and Ochel HJ}, journal={J Cancer Res Clin Oncol}}"}}, {"_id": "35691993", "pmid": 35691993, "title": "Simvastatin inhibits prostatic hyperplasia in rats with metabolic syndrome.", "journal": "Int Urol Nephrol", "authors": ["Gong YM", "Wang X", "Liu S", "Hu XC", "Xu Y", "Huang T"], "date": "2022-09-01T00:00:00Z", "doi": "10.1007/s11255-022-03227-z", "meta_date_publication": "2022 Sep", "meta_volume": "54", "meta_issue": "9", "meta_pages": "2125-2131", "score": 50261.676, "text_hl": "Level of serum @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@, prostatic weight, @DISEASE_Hyperplasia @DISEASE_MESH:D006965 @@@hyperplasia@@@ as well as expressions of @GENE_IL6 @GENE_24498 @@@IL-6@@@, @GENE_TNF @GENE_24835 @@@TNF-alpha@@@ and @GENE_IGF1 @GENE_24482 @@@IGF-1@@@ in the blank and saline subgroups of HFD group were higher than that of ND group (P < 0.05). While @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ has significantly resisted the former effects of HFD on serum @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ and @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostate@@@ (P < 0.05). ", "citations": {"NLM": "Gong YM, Wang X, Liu S, Hu XC, Xu Y, Huang T. Simvastatin inhibits prostatic hyperplasia in rats with metabolic syndrome. Int Urol Nephrol. 2022 Sep;54(9):2125-2131. PMID: 35691993", "BibTeX": "@article{35691993, title={Simvastatin inhibits prostatic hyperplasia in rats with metabolic syndrome.}, author={Gong YM and Wang X and Liu S and Hu XC and Xu Y and Huang T}, journal={Int Urol Nephrol}, volume={54}, number={9}, pages={2125-2131}}"}}, {"_id": "33368314", "pmid": 33368314, "title": "LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway.", "journal": "J Cell Physiol", "authors": ["Jung YY", "Ko JH", "Um JY", "Chinnathambi A", "Alharbi SA", "Sethi G", "Ahn KS"], "date": "2021-07-01T00:00:00Z", "doi": "10.1002/jcp.30229", "meta_date_publication": "2021 Jul", "meta_volume": "236", "meta_issue": "7", "meta_pages": "5253-5264", "score": 50248.59, "text_hl": "However, deletion of LDL-activated @GENE_STAT3 @GENE_6774 @@@STAT3@@@ in @CELLLINE_CVCL:0395 @@@LNCaP@@@ and @CELLLINE_CVCL:0480 @@@PANC-1@@@ cells and reduced LDL-induced cell viability. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SV@@@) treatment also alleviated LDL-induced cell viability and migration ability in both the @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostate and pancreatic tumor@@@ cells. ", "citations": {"NLM": "Jung YY, Ko JH, Um JY, Chinnathambi A, Alharbi SA, Sethi G, Ahn KS. LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway. J Cell Physiol. 2021 Jul;236(7):5253-5264. PMID: 33368314", "BibTeX": "@article{33368314, title={LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway.}, author={Jung YY and Ko JH and Um JY and Chinnathambi A and Alharbi SA and Sethi G and Ahn KS}, journal={J Cell Physiol}, volume={236}, number={7}, pages={5253-5264}}"}}, {"_id": "23559257", "pmid": 23559257, "title": "Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasis.", "journal": "J Cell Physiol", "authors": ["Al-Husein B", "Goc A", "Somanath PR"], "date": "2013-11-01T00:00:00Z", "doi": "10.1002/jcp.24381", "meta_date_publication": "2013 Nov", "meta_volume": "228", "meta_issue": "11", "meta_pages": "2139-48", "score": 50061.46, "text_hl": "Suppression of interactions between @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostate tumor@@@ cell-surface integrin and endothelial @GENE_ICAM1 @GENE_3383 @@@ICAM-1@@@ by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ inhibits micrometastasis.", "citations": {"NLM": "Al-Husein B, Goc A, Somanath PR. Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasis. J Cell Physiol. 2013 Nov;228(11):2139-48. PMID: 23559257", "BibTeX": "@article{23559257, title={Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasis.}, author={Al-Husein B and Goc A and Somanath PR}, journal={J Cell Physiol}, volume={228}, number={11}, pages={2139-48}}"}}, {"_id": "19301305", "pmid": 19301305, "title": "Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations.", "journal": "Prostate", "authors": ["Murtola TJ", "Pennanen P", "Syvälä H", "Bläuer M", "Ylikomi T", "Tammela TL"], "date": "2009-06-15T00:00:00Z", "doi": "10.1002/pros.20951", "meta_date_publication": "2009 Jun 15", "meta_volume": "69", "meta_issue": "9", "meta_pages": "1017-23", "score": 50057.84, "text_hl": "Effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@acetylsalicylic acid@@@, and @CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@ on proliferation of normal and cancerous @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostate@@@ epithelial cells at therapeutic concentrations.", "citations": {"NLM": "Murtola TJ, Pennanen P, Syvälä H, Bläuer M, Ylikomi T, Tammela TL. Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations. Prostate. 2009 Jun 15;69(9):1017-23. PMID: 19301305", "BibTeX": "@article{19301305, title={Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations.}, author={Murtola TJ and Pennanen P and Syvälä H and Bläuer M and Ylikomi T and Tammela TL}, journal={Prostate}, volume={69}, number={9}, pages={1017-23}}"}}, {"_id": "27900797", "pmid": 27900797, "title": "Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.", "journal": "Prostate", "authors": ["Masko EM", "Alfaqih MA", "Solomon KR", "Barry WT", "Newgard CB", "Muehlbauer MJ", "Valilis NA", "Phillips TE", "Poulton SH", "Freedland AR", "Sun S", "Dambal SK", "Sanders SE", "Macias E", "Freeman MR", "Dewhirst MW", "Pizzo SV", "Freedland SJ"], "date": "2017-04-01T00:00:00Z", "doi": "10.1002/pros.23282", "meta_date_publication": "2017 Apr", "meta_volume": "77", "meta_issue": "5", "meta_pages": "446-457", "score": 50052.727, "text_hl": "Tumoral RNA was extracted and cDNA synthesized from 1 ug of total RNA for quantitative real-time PCR. RESULTS: @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ directly reduced in vitro @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostate@@@ cell proliferation in a dose-dependent, cell line-specific manner, but @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ had no effect. ", "citations": {"NLM": "Masko EM, Alfaqih MA, Solomon KR, Barry WT, Newgard CB, Muehlbauer MJ, Valilis NA, Phillips TE, Poulton SH, Freedland AR, Sun S, Dambal SK, Sanders SE, Macias E, Freeman MR, Dewhirst MW, Pizzo SV, Freedland SJ. Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model. Prostate. 2017 Apr;77(5):446-457. PMID: 27900797", "BibTeX": "@article{27900797, title={Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.}, author={Masko EM and Alfaqih MA and Solomon KR and Barry WT and Newgard CB and Muehlbauer MJ and Valilis NA and Phillips TE and Poulton SH and Freedland AR and Sun S and Dambal SK and Sanders SE and Macias E and Freeman MR and Dewhirst MW and Pizzo SV and Freedland SJ}, journal={Prostate}, volume={77}, number={5}, pages={446-457}}"}}, {"_id": "25122066", "pmid": 25122066, "title": "Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.", "journal": "Mol Cancer Ther", "authors": ["Babcook MA", "Shukla S", "Fu P", "Vazquez EJ", "Puchowicz MA", "Molter JP", "Oak CZ", "MacLennan GT", "Flask CA", "Lindner DJ", "Parker Y", "Daneshgari F", "Gupta S"], "date": "2014-10-01T00:00:00Z", "doi": "10.1158/1535-7163.MCT-14-0451", "meta_date_publication": "2014 Oct", "meta_volume": "13", "meta_issue": "10", "meta_pages": "2288-302", "score": 50047.633, "text_hl": "Studies of @CELLLINE_CVCL:4787 @@@C4-2B4@@@ orthotopic NCr-nu/nu @SPECIES_10090 @@@mice@@@ further demonstrated that combination of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ (3.5-7.0 mug/g body weight @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and 175-350 mug/g body weight @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@) daily by oral gavage over a 9-week period significantly inhibited primary ventral @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostate tumor@@@ formation, @DISEASE_Cachexia @DISEASE_MESH:D002100 @@@cachexia@@@, @DISEASE_Neoplasm_Metastasis @DISEASE_MESH:D009362 @@@bone metastasis@@@, and biochemical failure more effectively than 24 mug/g body weight @CHEMICAL_Docetaxel @CHEMICAL_MESH:D000077143 @@@docetaxel@@@ intraperitoneally injected every 3 weeks, 7.0 mug/g/day @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, or 350 mug/g/day @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment alone, with significantly less @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@toxicity@@@ and mortality than @CHEMICAL_Docetaxel @CHEMICAL_MESH:D000077143 @@@docetaxel@@@, establishing combination of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ as a promising chemotherapeutic alternative for metastatic @DISEASE_Prostatic_Neoplasms_Castration_Resistant @DISEASE_MESH:D064129 @@@CRPC@@@.", "citations": {"NLM": "Babcook MA, Shukla S, Fu P, Vazquez EJ, Puchowicz MA, Molter JP, Oak CZ, MacLennan GT, Flask CA, Lindner DJ, Parker Y, Daneshgari F, Gupta S. Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer. Mol Cancer Ther. 2014 Oct;13(10):2288-302. PMID: 25122066", "BibTeX": "@article{25122066, title={Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.}, author={Babcook MA and Shukla S and Fu P and Vazquez EJ and Puchowicz MA and Molter JP and Oak CZ and MacLennan GT and Flask CA and Lindner DJ and Parker Y and Daneshgari F and Gupta S}, journal={Mol Cancer Ther}, volume={13}, number={10}, pages={2288-302}}"}}, {"_id": "21059805", "pmid": 21059805, "title": "Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.", "journal": "J Pharmacol Exp Ther", "authors": ["Kochuparambil ST", "Al-Husein B", "Goc A", "Soliman S", "Somanath PR"], "date": "2011-02-01T00:00:00Z", "doi": "10.1124/jpet.110.174870", "meta_date_publication": "2011 Feb", "meta_volume": "336", "meta_issue": "2", "meta_pages": "496-505", "score": 50047.344, "text_hl": "Our findings demonstrate the therapeutic benefits of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ for @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@prostate cancer@@@ and suggest a link between @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, regulation of @GENE_AKT1 @GENE_207 @@@Akt@@@ activity, and @GENE_KLK3 @GENE_354 @@@PSA@@@ expression in @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostate tumors@@@.", "citations": {"NLM": "Kochuparambil ST, Al-Husein B, Goc A, Soliman S, Somanath PR. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression. J Pharmacol Exp Ther. 2011 Feb;336(2):496-505. PMID: 21059805", "BibTeX": "@article{21059805, title={Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.}, author={Kochuparambil ST and Al-Husein B and Goc A and Soliman S and Somanath PR}, journal={J Pharmacol Exp Ther}, volume={336}, number={2}, pages={496-505}}"}}, {"_id": "24932304", "pmid": 24932304, "pmcid": "PMC4049715", "title": "Enhanced antitumor effects of low-frequency ultrasound and microbubbles in combination with simvastatin by downregulating caveolin-1 in prostatic DU145 cells", "journal": "Oncol Lett", "authors": ["Xu WP", "Shen E", "Bai WK", "Wang Y", "Hu B"], "date": "2014-06-01T00:00:00Z", "doi": "10.3892/ol.2014.2005", "meta_date_publication": "2014 Jun", "meta_volume": "7", "meta_issue": "6", "meta_pages": "2142-2148", "score": 50046.875, "text_hl": "Low-frequency ultrasound (LFU) has potential clinical applications in the treatment of @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@prostate cancer@@@ due to its strong penetrability and high sensitivity towards @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ cells. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ has often been administered as a preventive agent in @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostate tumors@@@. ", "citations": {"NLM": "Xu WP, Shen E, Bai WK, Wang Y, Hu B. Enhanced antitumor effects of low-frequency ultrasound and microbubbles in combination with simvastatin by downregulating caveolin-1 in prostatic DU145 cells Oncol Lett. 2014 Jun;7(6):2142-2148. PMID: 24932304", "BibTeX": "@article{24932304, title={Enhanced antitumor effects of low-frequency ultrasound and microbubbles in combination with simvastatin by downregulating caveolin-1 in prostatic DU145 cells}, author={Xu WP and Shen E and Bai WK and Wang Y and Hu B}, journal={Oncol Lett}, volume={7}, number={6}, pages={2142-2148}}"}}, {"_id": "25412314", "pmid": 25412314, "pmcid": "PMC4260755", "title": "Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells", "journal": "Cell Death Dis", "authors": ["Babcook MA", "Sramkoski RM", "Fujioka H", "Daneshgari F", "Almasan A", "Shukla S", "Nanavaty RR", "Gupta S"], "date": "2014-11-20T00:00:00Z", "doi": "10.1038/cddis.2014.500", "meta_date_publication": "2014 Nov 20", "meta_volume": "5", "meta_issue": "11", "meta_pages": "e1536", "score": 50042.496, "text_hl": "We previously demonstrated that combination @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@) and @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ (@GENE_SLTM @GENE_79811 @@@MET@@@) ameliorates critical Warburg effect-related metabolic aberrations of @CELLLINE_CVCL:4784 @@@C4-2B@@@ cells, synergistically and significantly decreases @DISEASE_Prostatic_Neoplasms_Castration_Resistant @DISEASE_MESH:D064129 @@@CRPC@@@ cell viability and metastatic properties, with minimal effect on normal prostate epithelial cells, and inhibits primary @<m>DISEASE_Prostatitis</m> @DISEASE_MESH:D011472 @@@prostate tumor@@@ growth, @DISEASE_Neoplasm_Metastasis @DISEASE_MESH:D009362 @@@metastasis@@@, and biochemical failure in an orthotopic model of metastatic @DISEASE_Prostatic_Neoplasms_Castration_Resistant @DISEASE_MESH:D064129 @@@CRPC@@@, more effectively than @CHEMICAL_Docetaxel @CHEMICAL_MESH:D000077143 @@@docetaxel@@@ chemotherapy. ", "citations": {"NLM": "Babcook MA, Sramkoski RM, Fujioka H, Daneshgari F, Almasan A, Shukla S, Nanavaty RR, Gupta S. Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Cell Death Dis. 2014 Nov 20;5(11):e1536. PMID: 25412314", "BibTeX": "@article{25412314, title={Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells}, author={Babcook MA and Sramkoski RM and Fujioka H and Daneshgari F and Almasan A and Shukla S and Nanavaty RR and Gupta S}, journal={Cell Death Dis}, volume={5}, number={11}, pages={e1536}}"}}]}